Pandemic Influenza Preparedness And Response Plan

Pandemic Preparedness and Response Health Action Plan 2005
Trinidad and Tobago English PDF
National

AI-Generated Document Summary

Objectives

Provide Trinidad and Tobago with a dynamic national framework for influenza-pandemic prevention, preparedness, response and recovery, designed to minimise serious illness, deaths and societal disruption.The Plan uses World Health Organization pandemic phases to organise scalable action, while allowing measures to be adapted to local epidemiology, triggers, resource availability and pandemic severity.

  • Strengthen surveillance, laboratory capacity, case detection, epidemiological assessment and rapid information-sharing for human and zoonotic influenza.
  • Prioritise vaccination as the principal preventive measure when available, with equitable allocation to high-risk groups and essential-service personnel where supply is constrained.
  • Use antivirals as an adjunct to vaccination, particularly during early pandemic periods when vaccine is unavailable, limited or not yet protective.
  • Maintain health-service continuity through surge planning for triage, hospital beds, intensive care, oxygen, ventilatory support, alternative care sites, transport, workforce shortages and mass fatalities.
  • Reduce transmission through infection prevention and control, hand hygiene, respiratory hygiene, patient cohorting, personal protective equipment, public-health measures and risk communication.
  • Protect essential social and economic functions, including utilities, transport, tourism, public confidence, environmental health and support for vulnerable people.
  • Integrate preparedness for animal influenza and other transboundary animal diseases, including joint action between health and agricultural authorities to manage avian-influenza risks.

Implementation

Deliver the Plan through coordinated national, regional and local action led by the Ministry of Health, supported by the Pandemic Influenza Committee, Task Force, Office of Disaster Preparedness and Management, Regional Health Authorities, County Medical Officers of Health, laboratories, emergency services and public and private partners.The Ministry of Health leads the national health response, policy, international liaison and vaccine-related functions, while regional and local authorities operationalise contingency plans and community delivery.

  • Activate phase-based measures through national, regional and local contingency plans, using local triggers and harmonised escalation or de-escalation as pandemic conditions develop.
  • Coordinate inter-ministerial crisis functions for health, safety and security, communications, diplomatic support, public utilities and economic sustainability.
  • Maintain surveillance through health centres, hospitals, emergency departments, general practitioners, regional authorities, the National Surveillance Unit and the Trinidad and Tobago Public Health Laboratory.
  • Strengthen laboratory operations through proficiency programmes, isolate submission, rapid sub-typing, enhanced sentinel surveillance, communication networks and preparedness for increased influenza and bacterial-pneumonia testing.
  • Secure vaccine and antiviral access through procurement arrangements, supplier engagement, alternative sources, stockpiling considerations and nationally controlled, priority-based distribution.
  • Establish vaccination delivery arrangements, including tracking and recall systems, mass-immunisation capacity, safety monitoring and reassessment of priority groups as epidemiological evidence emerges.
  • Prepare health facilities and non-traditional sites for triage, supportive care, step-down care, community care and referral, with assigned site management, patient-flow monitoring and supply oversight.
  • Manage resources system-wide by assessing beds, staff, supplies, equipment, transport and communications; centralise capacity tracking where appropriate; and reduce dependence on external assistance during simultaneous international demand.
  • Develop workforce and volunteer reserves through skills databases, training, redeployment, licensing and liability arrangements, worker immunisation, psychosocial support and family-care measures.
  • Apply infection-control plans across traditional and non-traditional settings, including hospitals, long-term care, home care, emergency services, schools, shelters, correctional facilities, child care and funeral services.
  • Implement public communications through prepared materials, spokespersons, stakeholder networks, secure information-sharing channels and public education on prevention, self-care and service use.
  • Use port-health measures, passenger declarations, vessel inspection, quarantine, referral pathways and protective procedures for personnel at points of entry.
  • Conduct recovery activities by restoring routine services, reviewing performance and disease burden, documenting lessons learnt, updating recommendations and preparing for later waves or future emerging infections.

Monitoring & Evaluation

The Plan establishes a broad monitoring and evaluation approach centred on surveillance, phased situational assessment, operational review and inter-agency reporting. It includes specific surveillance and quality-assurance activities, but does not provide a single consolidated national indicator framework, standard reporting timetable, audit system or performance-target set.

  • Conduct routine and enhanced surveillance for influenza, related disease events, vaccine adverse reactions and antiviral adverse effects, supported by national coordination and agreements with the World Health Organization and Pan American Health Organization.
  • Investigate outbreaks and clusters of influenza-like illness, report illness extent to the National Surveillance Unit and Trinidad Public Health Laboratory, and submit viral isolates for characterisation.
  • Assess pandemic progression against World Health Organization phase criteria, including transmission patterns, geographic spread, sustained transmission and affected-population characteristics.
  • Monitor vaccine coverage, disease impact, vaccine safety and effectiveness, and define adverse-reaction reporting mechanisms, time frames and acceptable reaction rates.
  • Track antiviral recipients, availability, uptake, wastage, resistance, adverse reactions and the effectiveness of strategic antiviral use.
  • Use laboratory proficiency requirements, isolate submission, sentinel surveillance, rapid sub-typing, communication of circulating strains and disaster drills to strengthen laboratory accountability and readiness.
  • Collect laboratory, influenza-like illness, hospitalisation and mortality data to guide prevention, control and prioritisation of scarce vaccine supplies; active surveillance includes daily reporting of suspected cases.
  • Use trigger indicators, including influenza-related emergency-room visits, hospitalisation rates, hospital capacity, unmet demand reported by sentinel providers and ambulance diversion, to activate phased health-service measures.
  • Review partner responses, response capacity, safety and performance criteria, simulation findings, post-pandemic outcomes and lessons learnt, and use findings to revise future preparedness and control measures.

Accountability is principally assigned through the Ministry of Health, Pandemic Influenza Committee, Task Force, Regional Health Authorities, National Surveillance Unit, Trinidad Public Health Laboratory and local authorities.Facility and setting-level plans add scheduled reviews, including annual interpandemic-plan reviews and three-yearly reviews of infection control and occupational health pandemic plans.Non-traditional sites are expected to maintain patient-flow and outcome logs and monitor supplies, while long-term care facilities must report suspected or confirmed outbreaks to public health authorities.

Several operational standards provide measurable controls, including analysis of an average of ten samples per month, submission of up to 10% of seasonal isolates for sub-typing, cleaning frequencies, sterilisation checks and defined laboratory thresholds.However, the document does not specify how these disparate measures will be aggregated, publicly reported or independently audited at national level.

Costing & Financing

The Plan recognises substantial resource and economic pressures from pandemic preparedness and response, including vaccine and antiviral procurement, surveillance adaptations, emergency supplies, surge capacity, workforce support, non-traditional sites and recovery. It assigns responsibilities for developing cost estimates but does not provide a consolidated budget, costed implementation plan, financing source, funding-gap assessment or resource-mobilisation target.

  • Develop national, regional and local health-sector cost estimates and options for decision-makers, including costs arising from modified surveillance activities, special studies and investigations.
  • Use contracts, manufacturers, suppliers, foreign governments and international agencies to secure vaccine and antiviral supplies, while recognising supply insecurity and limited global surge capacity.
  • Plan resource mobilisation and stockpiling for essential emergency supplies, vaccines, antivirals, medicines, equipment, communications, alternative care sites and workforce expansion.
  • Assess benefits, burdens and costs of response measures, including ethical decisions on scarce resources and prioritisation of vaccines, antivirals, beds, ventilators and care services.
  • Anticipate disrupted supply chains, limited inventories, international demand, export embargoes, transport constraints, workforce loss and restricted external assistance.
  • Address municipal financial implications and payment for staff recruited outside the health-care system when establishing non-traditional sites.
  • Consider economic sustainability as a crisis-management function intended to maintain public confidence and continuity of economic activity.

Explicit quantitative figures are generally health-impact or supply-planning assumptions rather than financial commitments. Planning includes an order for 26,000 seasonal influenza vaccine doses, preparedness to obtain at least three million pandemic vaccine doses, and an estimated pandemic attack rate of 15% to 35% with local waves lasting six to eight weeks.The document also identifies non-monetary economic considerations, including the lower cost of embedding preparedness features during construction, the expense of maintaining workforce and volunteer databases, and potential savings from reuse of disposable haemodialysers.

No financial valuation is provided for the projected health burden, including outpatient visits, hospitalisations and deaths, or for the additional requirements for beds, oxygen, ventilators, personal protective equipment, temporary morgues, transport and emergency logistics.

Document Viewer